Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1

Patients with sepsis have impaired host defenses that contribute to the lethality of the disorder. Recent work implicates lymphocyte apoptosis as a potential factor in the immunosuppression of sepsis. If lymphocyte apoptosis is an important mechanism, specific subsets of lymphocytes may be more vulnerable. A prospective study of lymphocyte cell typing and apoptosis was conducted in spleens from 27 patients with sepsis and 25 patients with trauma. Spleens from 16 critically ill nonseptic (3 prospective and 13 retrospective) patients were also evaluated. Immunohistochemical staining showed a caspase-9-mediated profound progressive loss of B and CD4 T helper cells in sepsis. Interestingly, sepsis did not decrease CD8 T or NK cells. Although there was no overall effect on lymphocytes from critically ill nonseptic patients (considered as a group), certain individual patients did exhibit significant loss of B and CD4 T cells. The loss of B and CD4 T cells in sepsis is especially significant because it occurs during life-threatening infection, a state in which massive lymphocyte clonal expansion should exist. Mitochondria-dependent lymphocyte apoptosis may contribute to the immunosuppression in sepsis by decreasing the number of immune effector cells. Similar loss of lymphocytes may be occurring in critically ill patients with other disorders.

[1]  H. Mann.  Recombinant human activated protein C in severe sepsis. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[2]  R. Hotchkiss,et al.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.

[3]  F. Lang,et al.  CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. , 2000, Science.

[4]  Nicholson,et al.  Cross-talk in cell death signaling , 2000, The Journal of experimental medicine.

[5]  V. Fadok,et al.  A receptor for phosphatidylserine-specific clearance of apoptotic cells , 2000, Nature.

[6]  R. Hotchkiss,et al.  p53-Dependent and -Independent Pathways of Apoptotic Cell Death in Sepsis1 , 2000, The Journal of Immunology.

[7]  L. Moldawer,et al.  Cytokine signaling--regulation of the immune response in normal and critically ill states. , 2000, Critical care medicine.

[8]  Graham P. Cook,et al.  Immunobiology: The Immune System in Health and Disease (4th edn) by C.A. Janeway, P. Travers, M. Walport and J.D. Capra , 2000 .

[9]  W. Pearce,et al.  Differential Effects of Necrotic or Apoptotic Cell Uptake on Antigen Presentation by Macrophages , 2000, Pathobiology.

[10]  K. Kuwano,et al.  Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family. , 2000, American journal of respiratory cell and molecular biology.

[11]  J. Puyana,et al.  Relationships between T lymphocyte apoptosis and anergy following trauma. , 2000, The Journal of surgical research.

[12]  S. Korsmeyer,et al.  Prevention of lymphocyte cell death in sepsis improves survival in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Remick,et al.  Endotoxin, sepsis, and the primrose path. , 1999, Shock.

[14]  C. Nathan,et al.  Molecular Medicine © 1999 The Picower Institute Press Original Articles Peptidomimetic Fluoromethylketone Rescues Mice from Lethal Endotoxic Shock , 1999 .

[15]  R. Hotchkiss,et al.  Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.

[16]  L. Moldawer.  Organ apoptosis in the septic patient: a potential therapeutic target? , 1999, Critical Care Medicine.

[17]  S. L. Murphy,et al.  Deaths: final data for 1997. , 1999, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[18]  S. Korsmeyer,et al.  Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. , 1999, Journal of immunology.

[19]  I. Chaudry,et al.  Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis? , 1999, Shock.

[20]  J. Cleveland,et al.  Neuroprotection by a caspase inhibitor in acute bacterial meningitis , 1999, Nature Medicine.

[21]  J. Lederer,et al.  The effects of injury on the adaptive immune response. , 1999, Shock.

[22]  C. Coopersmith,et al.  Bcl-2 inhibits ischemia-reperfusion-induced apoptosis in the intestinal epithelium of transgenic mice. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[23]  C. Coopersmith,et al.  Bcl-2 inhibits ischemia-reperfusion-induced apoptosis in the intestinal epithelium of transgenic mice. , 1999, The American journal of physiology.

[24]  G. Bernard.  Research in sepsis and acute respiratory distress syndrome: are we changing course? , 1999, Critical Care Medicine.

[25]  I. Chaudry,et al.  Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? , 1998, Archives of surgery.

[26]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[27]  I. Chaudry,et al.  Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. , 1998, Critical care medicine.

[28]  J. Puyana,et al.  Both T-helper-1- and T-helper-2-type lymphokines are depressed in posttrauma anergy. , 1998, The Journal of trauma.

[29]  S. Radinovic,et al.  Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. , 1998, Journal of molecular and cellular cardiology.

[30]  R. Voll,et al.  Immunosuppressive effects of apoptotic cells , 1997, Nature.

[31]  J. Lederer,et al.  Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. , 1997, Annals of surgery.

[32]  R. Hotchkiss,et al.  Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. , 1997, Critical care medicine.

[33]  R. Bone,et al.  Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.

[34]  I. Chaudry,et al.  Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. , 1996, Blood.

[35]  P. Norman,et al.  Immunobiology: The immune system in health and disease , 1995 .

[36]  I. Chaudry,et al.  THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS: CONTROL BY CORTICOSTEROIDS BUT NOT TUMOR NECROSIS FACTOR , 1995, Shock.

[37]  Jean-Claude Martinou,et al.  Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia , 1994, Neuron.

[38]  C. Natanson,et al.  Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis , 1994, Annals of Internal Medicine.

[39]  J. L. Rodriguez,et al.  Lymphocyte subset responses to trauma and sepsis. , 1993, The Journal of trauma.

[40]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[41]  M. Colombel,et al.  Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. , 1992, The American journal of pathology.

[42]  J. Meakins,et al.  The delayed hypersensitivity response: application in clinical surgery. , 1977, Surgery.

[43]  J. Meakins,et al.  Delayed Hypersensitivity: Indicator of Acquired Failure of Host Defenses in Sepsis and Trauma , 1977, Annals of surgery.